Mid-Year Report

THE LIVINGSTON GROUP, LLC for PKD FOUNDATION

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 (HR 3282) HHS, Defense Appropriations for research and clinical funding for PKD (HR 3043, S 1710; HR 3222); Genetic Information Nondiscrimination Legislation (HR 493; S 358); National PKD Awareness Week Resolution (S. Res. 282);

LobbyistCovered position, as disclosed
ROBERT L LIVINGSTON N/A
J ALLEN MARTIN N/A

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3282 (110th), H.R. 3222 (110th), S.Res. 282 (110th), H.R. 493 (110th), H.R. 3043 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.